FluidSpec™ brings the GC-IMS capabilities to bear on liquid and solid headspace analyses such as those done to detect infectious diseases such as Group B Streptococcus. This device brings all the established functionality of the Imspex group’s FlavourSpec® device with a rebranded identity that fits comfortably in a medical market. Analysis is automated and results are produced within minutes. The device has demonstrated particular accuracy with disease indications such as Group B Streptococcus infection with 89% specificity and 95% sensitivity